doravirine
Delstrigo Demonstrates Long-Term HIV Suppression
Adults with HIV who were switched to the once-daily, fixed-dose Delstrigo combination tablet saw virologic ...
OCTOBER 5, 2018
FDA Approves Delstrigo and Pifeltro for HIV Treatment
The FDA approved Merck’s two doravirine-based HIV-1 medicines: Delstrigo, a once-daily fixed-dose combination ...
AUGUST 30, 2018
Investigational ART Efficacious, Well Tolerated
Doravirine (Merck), a late-stage investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), was found ...
MARCH 9, 2018
Load more